FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Emalex Ecopipam Meets Tourette Study Endpoints

Emalex Biosciences says it will meet with FDA to discuss submitting an NDA for its ecopipam to treat Tourette syndrome following successful results fr...

latest-news-card-1
Medical Devices

Tandem Diabetes Insulin Algorithm Cleared for Type 2

FDA clears Tandem Diabetes Cares next-generation automated insulin delivery algorithm, Control-IQ+ technology, for use in people with Type 2 diabetes....

latest-news-card-1
Human Drugs

Contaminated SinuCleanse Nasal Wash Recalled

Ascent Consumer Products recalls one lot of its SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System following a confirmed test result of microbial c...

Biologics

Invivyd EUA Request to Expand Covid Therapy Denied

FDA rejects an Invivyd request to expand the existing emergency use authorization for pre-exposure prophylaxis of Covid-19 EUA for Pemgarda (pemivibar...

latest-news-card-1
Human Drugs

Entrada Clinical Hold Lifted on Duchenne Drug

FDA lifts a 12/2022-ordered clinical hold on Entrada Therapeutics Duchenne muscular dystrophy therapy ENTR-601-44 and provided authorization to begin ...

Human Drugs

Ex-CDER Head Cavazzoni Rejoins Pfizer

Former CDER director Patrizia Cavazzoni rejoins Pfizer as the companys chief medical officer.

latest-news-card-1
Human Drugs

Medtronics Brain Stimulator for Parkinsons Approved

FDA approves a Medtronic PMA for its BrainSense Adaptive deep brain stimulation and BrainSense Electrode Identifier for use in Parkinsons patients.

latest-news-card-1
Human Drugs

FDA Trying to Rehire 300 Staff Recently Fired

FDA moves over the weekend to rehire up to 300 scientists and reviewers who were terminated last week as part of the Trump Administrations cost-cuttin...

latest-news-card-1
Human Drugs

No Panel Meeting for Brensocatib NDA

FDA tells Insmed that it does not currently plan to hold an advisory committee meeting to discuss the companys NDA for brensocatib for patients with n...

latest-news-card-1
Human Drugs

BMS Files sBLA for Opdivo+Yervoy in Colon Cancer

FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Opdivo (nivolumab) plus Yervoy (ipilimumab) for a first-line treatment opt...